National Resource Center for Academic Detailing [NaRCAD]
NARCAD
  • About
    • Why We Matter
    • Testimonials
    • Our Team
    • Contact Us
  • Tools & Resources
    • AD Core Toolkits >
      • Inclusivity Toolkit
      • Opioid Safety Toolkit
      • HIV Prevention Toolkit
      • E-Detailing Toolkit
      • Materials Toolkit
    • AD Literature Archives
  • Webinars
    • Webinar Series
    • E-Detailing Webinars
    • E-Detailing Roundtables
  • Blog & E-News
    • Best Practices Blog
    • E-Newsletter
  • Community
    • Discussion Forum
    • Peer Connection Program
    • Detailing Partners
  • EVENTS
    • Training Series
    • CONFERENCE SERIES
    • AD Summit Series
    • Present at NaRCAD2023
    • THE CONFERENCE HUB
  • About
    • Why We Matter
    • Testimonials
    • Our Team
    • Contact Us
  • Tools & Resources
    • AD Core Toolkits >
      • Inclusivity Toolkit
      • Opioid Safety Toolkit
      • HIV Prevention Toolkit
      • E-Detailing Toolkit
      • Materials Toolkit
    • AD Literature Archives
  • Webinars
    • Webinar Series
    • E-Detailing Webinars
    • E-Detailing Roundtables
  • Blog & E-News
    • Best Practices Blog
    • E-Newsletter
  • Community
    • Discussion Forum
    • Peer Connection Program
    • Detailing Partners
  • EVENTS
    • Training Series
    • CONFERENCE SERIES
    • AD Summit Series
    • Present at NaRCAD2023
    • THE CONFERENCE HUB

The DETAILS BLOG

Capturing Stories from the Field: Reflections, Challenges, & Best Practices

Evidence, Education, and Equity: Lessons for Academic Detailing as We Look Past COVID-19

10/20/2021

 
Picture
Jerry Avorn, M.D.
Professor of Medicine, Harvard Medical School

NaRCAD Co-Founder & Special Adviser

Tags: 
Evidence Based Medicine, COVID 19, Jerry Avorn
​
​
We’ve lived through the vast human tragedy this virus has inflicted, and witnessed the heroic work of our colleagues in the medical and public health sectors. We now see clearly the disproportionate damage it did to the most vulnerable in our country and around the world.
​
And the coronavirus has also had lessons to offer our little academic detailing community. While more modest in scale, they’re worth considering, even as the worst days of the pandemic continue (we hope) to fade.

Picture
​Lesson One was a re-demonstration of the validity of Avorn’s 6th Law: “Good information doesn’t disseminate itself.” In the most striking possible way, the pandemic rubbed our noses in the fact that just because a medical intervention is very effective and safe, it doesn’t mean that everyone will understand that and use it appropriately – or that a useless and/or dangerous treatment won’t become appallingly popular. The therapeutic misstatements of the former President undermined trust in science badly, and many have become blind to first-rate evidence and disbelieve it.

Even today, the flawed communication efforts of the CDC, FDA, and current administration all remind us that even when the scientific Truth Is Out There, it can still be conveyed poorly: more proof that the completion of rigorous, compelling randomized clinical trials is just the beginning, not the end of the journey. Getting the message out, and acted on, is key.

Picture
Lesson Two was about the centrality of front-line health care providers, rational health care delivery policies, and our battered but heroic public health infrastructure. Without the effort to get those pieces right, even gallons of messenger RNA would not have been able to turn the tide on the pandemic. And communication of the best science at all of these levels was central to making the system work, even if imperfectly. Two Boston institutions worked together to create COVIDProtocols.org as a real-time way to aggregate the evidence and practical clinical tips as they emerged.

Picture
Lesson Three was about communication and empathy. Academic detailers saw how each health care professional they engaged with was giving some of their scarce free time to learn how to care for their patients better – even in the face of overwhelming job demands. While a year and a half of e-Detailing sessions maintained connections and provided a serviceable fallback that was much better than no contact, it also reminded us again of the added value of being there in person: the human contact, the body language, the less stilted give-and-take.

Picture
Finally, COVID-19’s Fourth Lesson was about how unevenly we distribute medical resources. We saw more clearly than ever how crucial science-based care is in enabling societies to function – and what happens when those are missing. The U.S. blew past issues of affordability when the federal government wrote a blank check to pay for the vaccine, monoclonal antibody treatment, and (probably) even Merck’s new oral anti-viral pill, making COVID-19 practically the only medical condition for which the nation assures full coverage to all US residents.

Picture
But COVID-19 also provided us with yet another opportunity to discover how crucial public – taxpayer – funding is for the development of innovative new medical products, and to ask once again how drugmakers can continue to charge sky-high prices for these products after they’ve patented them.


The scientific triumphs of the COVID-19 era have been remarkable. But as we move into what we hope will be the Waning Pandemic Era, it’s a good time to also reflect on the less-heralded but vital role played by evidence-based communication, outreach to health care professionals and their patients, and the importance of fairness in making the victories of medical science available more equitably to all who need them.

​Have thoughts on our DETAILS Blog posts?
You can head on over to our Discussion Forum to continue the conversation!

Biography. 
​
Jerry Avorn, MD, Co-Founder & Special Adviser, NaRCAD

Dr. Avorn is Professor of Medicine at Harvard Medical School and Chief Emeritus of the Division of Pharmacoepidemiology and Pharmacoeconomics (DoPE) at Brigham & Women's Hospital. A general internist, geriatrician, and drug epidemiologist,  he pioneered the concept of academic detailing and is recognized internationally as a leading expert on this topic and on optimal medication use, particularly in the elderly. Read More.

Comments are closed.

    Highlighting Best Practices

    We highlight what's working in clinical education through interviews, features, event recaps, and guest blogs, offering clinical educators the chance to share successes and lessons learned from around the country & beyond.

    Search Archives
    by Topic:

    All
    Autism
    Cancer
    Cardiovascular Health
    Chronic Illness
    CME
    Conference
    COVID 19
    Data
    Deprescribing
    Detailing Visits
    Diabetes
    Director's Letter
    E Detailing
    Elderly Care
    Evaluation
    Evidence Based Medicine
    Expert Trainer Insight Series
    Harm Reduction
    Health Disparities
    Health Policy
    Hepatitis C
    HIV/AIDS
    International
    Jerry Avorn
    LOOPR
    Materials Development
    Medications
    Mental Health
    Obesity
    Opioid Safety
    Pediatrics
    Practice Facilitation
    PrEP
    Primary Care
    Program Management
    Rural AD Programs
    Sexual Health
    Smoking Cessation
    Stigma
    Substance Use
    Sustainability
    Training
    Vaccinations

    RSS Feed


​NaRCAD is a program of the Boston Medical Center, founded at the Division of Pharmacoepidemiology & Pharmacoeconomics [DoPE], at Brigham & Women's Hospital.

​Privacy Notice
Proudly powered by Weebly